These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38392856)

  • 21. Host Immune Responses to
    Alam MZ; Markantonis JE; Fallon JT
    Trop Med Infect Dis; 2023 Nov; 8(12):. PubMed ID: 38133438
    [No Abstract]   [Full Text] [Related]  

  • 22. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
    Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
    Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the Toxin-Mediated Mechanisms in
    Pourliotopoulou E; Karampatakis T; Kachrimanidou M
    Microorganisms; 2024 May; 12(5):. PubMed ID: 38792835
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in Therapeutic Strategies for the Management of
    Vitiello A; Sabbatucci M; Zovi A; Salzano A; Ponzo A; Boccellino M
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies.
    Berry P; Khanna S
    BioDrugs; 2023 Nov; 37(6):757-773. PubMed ID: 37493938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbial ecology between
    Kamiya S
    Biosci Microbiota Food Health; 2023; 42(4):229-235. PubMed ID: 37791342
    [No Abstract]   [Full Text] [Related]  

  • 28. Overview of current detection methods and microRNA potential in
    Bocchetti M; Ferraro MG; Melisi F; Grisolia P; Scrima M; Cossu AM; Yau TO
    World J Gastroenterol; 2023 Jun; 29(22):3385-3399. PubMed ID: 37389232
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathogenicity and virulence of
    Buddle JE; Fagan RP
    Virulence; 2023 Dec; 14(1):2150452. PubMed ID: 36419222
    [No Abstract]   [Full Text] [Related]  

  • 31. An insight into
    Thabit AK; Aljedaani HJ; Alghamdi RH; Badahdah RM; Lashkar MO; Alnajjar A
    Expert Rev Gastroenterol Hepatol; 2023; 17(8):805-810. PubMed ID: 37480286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
    Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
    Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.
    Costa DVS; Pham NVS; Hays RA; Bolick DT; Goldbeck SM; Poulter MD; Hoang SC; Shin JH; Wu M; Warren CA
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0048922. PubMed ID: 35861541
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Saenz C; Fang Q; Gnanasekaran T; Trammell SAJ; Buijink JA; Pisano P; Wierer M; Moens F; Lengger B; Brejnrod A; Arumugam M
    Microbiol Spectr; 2023 Sep; 11(5):e0393322. PubMed ID: 37750706
    [No Abstract]   [Full Text] [Related]  

  • 35. A dual-action antibiotic that kills
    Janardhanan J; Kim C; Qian Y; Yang J; Meisel JE; Ding D; Speri E; Schroeder VA; Wolter WR; Oliver AG; Mobashery S; Chang M
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2304110120. PubMed ID: 37155891
    [No Abstract]   [Full Text] [Related]  

  • 36. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.
    Abad CLR; Safdar N
    Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the diagnosis and treatment of Clostridium difficile infections.
    Peng Z; Ling L; Stratton CW; Li C; Polage CR; Wu B; Tang YW
    Emerg Microbes Infect; 2018 Feb; 7(1):15. PubMed ID: 29434201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance and genomic features of
    Gu W; Li W; Jia S; Zhou Y; Yin J; Wu Y; Fu X
    PeerJ; 2022; 10():e14016. PubMed ID: 36093337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridioides difficile: Current overview and future perspectives.
    Giles J; Roberts A
    Adv Protein Chem Struct Biol; 2022; 129():215-245. PubMed ID: 35305720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.
    Shah MD; Balada-Llasat JM; Coe K; Reed E; Sandlund J; Pancholi P
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32051264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.